返回
IO Biotech Inc（IOBT）價格
IOBT 股價走勢圖
IOBT 收益
IO Biotech Inc
$0.5
-2.69%
$-0.01
收盤價：Jan 16, 16:00:00 GMT-5
$0.51
1.57%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.516
開盤價
$0.516
當日範圍
$0.5 - $0.516
52週區間
$0.323 - $2.79
交易量
436.1K
平均成交量
2.2M
每股盈餘 (TTM)
-1.34
股息收益率
--
市值
$36.6M
什麼是 IOBT？
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.